(Q34282031)

1 August 2017

1 reference

title

Lithium for maintenance treatment of mood disorders (English)

1 reference

1 August 2017

0 references

S Burgess

1

1 reference

1 August 2017

J Geddes

2

1 reference

1 August 2017

K Hawton

3

1 reference

1 August 2017

E Townsend

4

1 reference

1 August 2017

K Jamison

5

1 reference

1 August 2017

G Goodwin

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

1 August 2017

2001

0 references

published in

1 reference

1 August 2017

2

1 reference

1 August 2017

3

0 references

page(s)

CD003013

1 reference

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

1 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Prophylactic lithium in affective disorders. Controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Methodologic issues in maintenance therapy clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

A double-blind trial of long-term lithium therapy in mental defectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Lithium treatment of depressed and nondepressed alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

A hundred cases of suicide: clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Prevention of suicide: aspirations and evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Suicide as an outcome for mental disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Refractory depression: a review with particular reference to the use of lithium augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Mental disorders and suicide prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Lithium: evidence reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Lithium in the Prophylactic Treatment of Affective Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Efficacy of lithium as acute treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003013

10.1002/14651858.CD003013

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference